Localized scleroderma: clinical spectrum and therapeutic update.
Careta MF, Romiti R.
An Bras Dermatol. 2015 Jan-Feb;90(1):62-73. doi: 10.1590/abd1806-4841.20152890.
Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis.
Li SC.
Pediatr Clin North Am. 2018 Aug;65(4):757-781. doi: 10.1016/j.pcl.2018.04.002.
Update on the classification and treatment of localized scleroderma.
Bielsa Marsol I.
Actas Dermosifiliogr. 2013 Oct;104(8):654-66. doi: 10.1016/j.adengl.2012.10.012. Epub 2013 Aug 13.
Localized scleroderma/morphea.
Sehgal VN, Srivastava G, Aggarwal AK, Behl PN, Choudhary M, Bajaj P.
Int J Dermatol. 2002 Aug;41(8):467-75. doi: 10.1046/j.1365-4362.2002.01469.x.
Upcoming treatments for morphea.
Wenzel D, Haddadi NS, Afshari K, Richmond JM, Rashighi M.
Immun Inflamm Dis. 2021 Dec;9(4):1101-1145. doi: 10.1002/iid3.475. Epub 2021 Jul 17.
Morphea (localized scleroderma).
Fett NM.
JAMA Dermatol. 2013 Sep;149(9):1124. doi: 10.1001/jamadermatol.2013.5079.
[Morphea or localized scleroderma and extragenital lichen sclerosus].
Moinzadeh P, Kreuter A, Krieg T, Hunzelmann N.
Hautarzt. 2018 Nov;69(11):892-900. doi: 10.1007/s00105-018-4266-7.
Morphea and other localized forms of scleroderma.
Vasquez R, Sendejo C, Jacobe H.
Curr Opin Rheumatol. 2012 Nov;24(6):685-93. doi: 10.1097/BOR.0b013e32835896ce.
Endpoints and outcomes for localized scleroderma/morphea: a scoping literature review.
Hernandez A, Zapata Leiva L, Mutka M, Torok KS, Ledbetter L, Zigler CK.
Pediatr Rheumatol Online J. 2024 Aug 21;22(1):77. doi: 10.1186/s12969-024-01014-x.
Localized scleroderma.
Kreuter A.
Dermatol Ther. 2012 Mar-Apr;25(2):135-47. doi: 10.1111/j.1529-8019.2012.01479.x.
